Norbert Avril

University Hospitals Seidman Cancer Center — United States

Medicine · Health Sciences

54h-index11.3kcitations214works7.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(81), Radiomics and Machine Learning in Medical Imaging(60), Cancer, Hypoxia, and Metabolism(34), Radiopharmaceutical Chemistry and Applications(31), Ovarian cancer diagnosis and treatment(29)

Publications213 total

F18-FDG PET imaging as a diagnostic tool for immune checkpoint inhibitor–associated acute kidney injury
Journal of Clinical Investigation·2024· 12 citedOpen Access
Advances in prostate cancer treatment: Radionuclide therapy for prostate cancer
Advances in cancer research·2024· 3 cited
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate
Journal of Clinical Oncology·2023· 27 citedOpen Access
Pretreatment and Posttreatment Tumor Metabolic Activity Assessed by FDG-PET/CT as Predictors of Tumor Recurrence and Survival Outcomes in Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy
Advances in Radiation Oncology·2023· 1 citedOpen Access
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)
European Urology·2023· 86 citedOpen Access
Diagnostic Performance and Safety of <sup>18</sup> F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)
The Journal of Urology·2023· 62 citedOpen Access
The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experience
Journal of Gastrointestinal Oncology·2023· 7 citedOpen Access
Supplementary Figure 2 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Supplementary Figure Legends 1-3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Supplementary Figure 3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Supplementary Figure 1 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Supplementary Figure 3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Data from Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
2023Open Access
Supplementary Figure Legends 1-3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
CCR Translation for This Article from Sequential FDG-PET/CT as a Biomarker of Response to Sunitinib in Metastatic Clear Cell Renal Cancer
2023Open Access
Supplementary Appendix 2 from Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test–Retest Measurements for Tumor FDG Uptake, Diameter, and Volume
2023Open Access
Supplementary Appendix 2 from Repeatability of Quantitative FDG-PET/CT and Contrast-Enhanced CT in Recurrent Ovarian Carcinoma: Test–Retest Measurements for Tumor FDG Uptake, Diameter, and Volume
2023Open Access
Data from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Data from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
Supplementary Tables 1-3 from Interleukin-6 as a Therapeutic Target in Human Ovarian Cancer
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Markus Schwaiger(17), Wolfgang Weber(12), F. Jänicke(7), J. Dose(6), H. Graeff(5), Wolfgang Römer(4), Stefanie Sassen(4), C. Laubenbacher(4), Barry A. Siegel(3), M. Schelling(3), Sandra Bense(3), Martin Werner(3), W. Nathrath(3), Michael Herz(3), Sibylle Ziegler(3), Sven� Mahner(3), Peter W. Szlosarek(3), Phuong Luong(3), Iain Murray(3), Ashley Grossman(3)